<ARTICLE> 5 <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> MAR-31-1996 <CASH> 898,400 <SECURITIES> 95,004 <RECEIVABLES> 1,552,083 <ALLOWANCES> 57,415 <INVENTORY> 843,670 <CURRENT-ASSETS> 3,847,465 <PP&E> 6,837,463 <DEPRECIATION> 2,623,341 <TOTAL-ASSETS> 14,160,373 <CURRENT-LIABILITIES> 4,436,476 <BONDS> 2,576,183 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 355,564 <OTHER-SE> 5,490,036 <TOTAL-LIABILITY-AND-EQUITY> 14,160,373 <SALES> 1,705,525 <TOTAL-REVENUES> 1,783,268 <CGS> 460,376 <TOTAL-COSTS> 517,932 <OTHER-EXPENSES> 736,046<F1> <LOSS-PROVISION> 0<F2> <INTEREST-EXPENSE> 69,880 <INCOME-PRETAX> 523,793 <INCOME-TAX> 134,611 <INCOME-CONTINUING> 389,182 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 389,182 <EPS-PRIMARY> .69 <EPS-DILUTED> .69 <FN> <F1>Note 1 - Amounts include research and development, selling and general and administrative expenses. <F2>Note 2 - The information called for is not given as the balances are not individually significant. </FN>